<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04462458</url>
  </required_header>
  <id_info>
    <org_study_id>P07.001.01</org_study_id>
    <nct_id>NCT04462458</nct_id>
  </id_info>
  <brief_title>M-ARS ACL Post-marketing Surveillance Study</brief_title>
  <official_title>Clinical and Radiological Outcomes of M-ARS ACL</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medacta International SA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medacta International SA</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to evaluate the performance of Medacta Anatomic Ribbon Surgery&#xD;
      (M-ARS) in patients requiring anterior cruciate ligament (ACL) reconstruction.&#xD;
&#xD;
      The main goal is to evaluate the survival rate of M-ARS ACL at 6 months post-operatively. The&#xD;
      secondary goals are to assess the survival rate, clinical and functional outcomes, the&#xD;
      quality of life, and the rate of complications at 1 month, 1 year and 2 years&#xD;
      post-operatively.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This s a prospective, multicenter, non-controlled, observational study to evaluate the&#xD;
      outcomes of Medacta Anatomic Ribbon Surgery (M-ARS) in the reconstruction of the anterior&#xD;
      cruciate ligament (ACL).&#xD;
&#xD;
      Participants will be informed about the study, both orally and in writing, during a&#xD;
      preoperative visit. The investigator will answer any questions that may arise and will&#xD;
      collect the informed consent. During the study, enrolled participants will be able to&#xD;
      withdraw at any time and for any reason.&#xD;
&#xD;
      The study is conducted according to the following schedule:&#xD;
&#xD;
        -  V1 : Inclusion during a preoperative visit&#xD;
&#xD;
        -  V2: Surgery&#xD;
&#xD;
        -  V3: Follow-up visit at 1 month ± 15 days post-surgery&#xD;
&#xD;
        -  V4: Follow-up visit at 6 months ± 30 days post-surgery&#xD;
&#xD;
        -  V5: Follow-up visit at 12 months ± 60 days post-surgery&#xD;
&#xD;
        -  V6: Follow-up visit at 24 months ± 90 days post-surgery&#xD;
&#xD;
      The following data will be collected:&#xD;
&#xD;
        -  Survival rate of implants evaluating the incidence of implants failure, where implant&#xD;
           failure is defined as revision, loosening, or any definite change in the position of&#xD;
           components (V3-V6).&#xD;
&#xD;
        -  Clinical and functional outcomes, measured with the International Knee Documentation&#xD;
           Committee (IKDC) score (V1, V3-V6)&#xD;
&#xD;
        -  Quality of Life, measured with the EQ-5D score (V1, V3-V6)&#xD;
&#xD;
        -  Occurrence of intraoperative and postoperative complications (V2-V6)&#xD;
&#xD;
      Depending on standard practice, imaging assessment of implants and bone tunnels may be&#xD;
      performed.&#xD;
&#xD;
      A web-based data collection tool will be used as Electronic Data Capture (EDC). All the&#xD;
      information required by the protocol will be collected in electronic case report forms&#xD;
      (eCRF).&#xD;
&#xD;
      The statistical analysis will be performed according to a pre-established statistical&#xD;
      analysis plan. Missing values will not be replaced by estimated values but will be considered&#xD;
      as missing in the statistical analysis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2021</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">July 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survival rate</measure>
    <time_frame>6 months</time_frame>
    <description>Kaplan Meier method</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Survival rate</measure>
    <time_frame>1, 12, 24 months</time_frame>
    <description>Kaplan Meier method</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional outcome</measure>
    <time_frame>1, 6, 12, 24 months</time_frame>
    <description>International Knee Documentation Committee (IKDC) score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life outcome</measure>
    <time_frame>1, 6, 12, 24 months</time_frame>
    <description>EQ-5D score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiological outcome (optional)</measure>
    <time_frame>1, 6, 12, 24 months</time_frame>
    <description>Evaluation of ligament osteointegration, femoral/tibial tunnel widening, presence of fluid in the femoral/tibial tunnel</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complication rate</measure>
    <time_frame>intraoperative, 1, 6, 12, 24 months</time_frame>
    <description>Occurrence of intraoperative and postoperative complications</description>
  </secondary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Anterior Cruciate Ligament (ACL) Reconstruction</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Medacta Anatomic Ribbon Surgery (M-ARS ACL)</intervention_name>
    <description>M-ARS ACL allows to reconstruct the anterior cruciate ligament using the Anatomic Ribbon Technique</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients requiring ACL reconstruction and who are suitable to receive M-ARS ACL will be&#xD;
        proposed to take part to the current post-marketing surveillance study during their&#xD;
        pre-operative visit.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients older than 18 years&#xD;
&#xD;
          -  Patients with ACL rupture requiring ACL reconstruction&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with malignant diseases (at the time of surgery)&#xD;
&#xD;
          -  Patients with proven or suspected infections (at the time of surgery)&#xD;
&#xD;
          -  Patients with functional deficits of the affected extremity (at the time of surgery)&#xD;
&#xD;
          -  Patients with known incompatibility or allergy to products materials (at the time of&#xD;
             surgery)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mirco Herbort, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>OCM Klinik GmbH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Denise Falcone</last_name>
    <phone>+41916966060</phone>
    <email>falcone@medacta.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Praxis Gelenkpunkt - Sport- und Gelenkchirurgie</name>
      <address>
        <city>Innsbruck</city>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Fink, Prof. Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pyhrn-Eisenwurzen Klinikum Kirchdorf</name>
      <address>
        <city>Kirchdorf An Der Krems</city>
        <zip>4560</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simone Danese, OA Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>OCM Klinik GmbH</name>
      <address>
        <city>München</city>
        <zip>81369</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 2, 2020</study_first_submitted>
  <study_first_submitted_qc>July 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 8, 2020</study_first_posted>
  <last_update_submitted>August 25, 2021</last_update_submitted>
  <last_update_submitted_qc>August 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

